Manipal Health lists at 11% premium, raising ₹9,275 crore for debt reduction and Sahyadri buyout

What to watch

• Quarterly net-debt reduction and interest-cost savings after IPO proceeds are deployed.
• Timing, purchase consideration and accounting treatment of the Sahyadri minority-stake acquisition.
• Sahyadri occupancy, margin trajectory and evidence of procurement or referral-network synergies.
• Post-listing share performance versus the ₹590 issue price and listed hospital peers.
• New hospital-chain M&A, private-equity investments or IPO filings that signal an accelerating consolidation cycle.
• Regulatory or insurer reimbursement changes that affect pricing power, payer mix and margins.
• Apply most fresh-issue proceeds toward debt repayment, lowering net leverage and annual finance costs.
• Complete the purchase of Sahyadri Hospitals' minority stake and begin operational integration across procurement, diagnostics, referrals and clinician networks.
• Use improved balance-sheet capacity to evaluate selective brownfield acquisitions and greenfield bed additions in western and southern India.
• Increase investor communication around occupancy, average revenue per occupied bed, payer mix, EBITDA margins and integration milestones to defend the post-listing valuation.